Click here to go to the previous page
Protein Manufacturing: From Art to Science to the Bottom Line
Program Code:
MAN070
Date:
Wednesday, May 9, 2007
Time:
4:00 PM to 5:30 PM
CHAIR
:
Timothy Charlebois, PhD, Director, Cell and Molecular Sciences, Wyeth Pharmaceuticals Inc.
SPEAKER
(S):
Dana Andersen, PhD, Director, Late Stage Cell Culture, Genentech, Inc.
Gary Pisano, PhD, Professor of Buisness Administration, Harvard Business School
Description
The session will discuss the impact of technological advances on the biopharmaceutical manufacturing industry and how these advances have been incorporated into practice among companies with varying business models and organizational structures.
Objectives:
Outline the different business models within the industry in relation to capacity planning, cost savings and speed to market.
Explain the impact of manufacturing processes on the penetration and sustainability of biopharmaceuticals in the global health-care market.
Discuss strategies to meet challenges associated with expanding biopharmaceutical pipelines and emerging global markets in an environment of limited resources.